What Faster Biosimilar Approvals Mean for U.S. Drug CostsBusiness PenOctober 31, 2025 October 31, 2025 One of the most persistent challenges in U.S. healthcare is the high cost of prescription drugs. Biologic medications, which treat many chronic and serious diseases,...